Isabel Kalofonos
Corporate Officer/Principal chez IMMUNOGEN, INC.
Postes actifs de Isabel Kalofonos
Sociétés | Poste | Début | Fin |
---|---|---|---|
IMMUNOGEN, INC. | Corporate Officer/Principal | 24/04/2023 | - |
Historique de carrière de Isabel Kalofonos
Anciens postes connus de Isabel Kalofonos
Sociétés | Poste | Début | Fin |
---|---|---|---|
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Corporate Officer/Principal | - | - |
Formation de Isabel Kalofonos
Pontificia Universidad Javeriana | Undergraduate Degree |
Babson College | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 3 |
Colombie | 2 |
Suisse | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Health Technology |
- Bourse
- Insiders
- Isabel Kalofonos
- Expérience